Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnex vs Ceftazidime+Amikacin+Metronidazole in Intra-Abdominal Infections
NCT00360607Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jul 2004
- Modality
- Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cefoperazone + sulbactam in intra-abdominal infections (IAI), sponsored by Pfizer. Started Jul 2004; status: completed.
02
Drugs
cefoperazone + sulbactam
03
Conditions
intra-abdominal infections (IAI)
Beyond the preview
Go deeper on NCT00360607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00360607.